# Acadia Pharmaceuticals Inc. (ACAD) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $1.07B |
| 2024 | $958M |
| 2023 | $726M |
| 2022 | $517M |
| 2021 | $484M |
| 2020 | $442M |
| 2019 | $339M |
| 2018 | $224M |
| 2017 | $125M |
| 2016 | $17M |
| 2015 | $61,000 |
| 2014 | $120,000 |
| 2013 | $1M |
| 2012 | $5M |
| 2011 | $2M |
| 2010 | $42M |
| 2009 | $6M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $268M |
| 2025-09-30 | $279M |
| 2025-06-30 | $265M |
| 2025-03-31 | $244M |
| 2024-09-30 | $250M |
| 2024-06-30 | $242M |
| 2024-03-31 | $206M |
| 2023-09-30 | $212M |
| 2023-06-30 | $165M |
| 2023-03-31 | $118M |
| 2022-09-30 | $131M |
| 2022-06-30 | $135M |
| 2022-03-31 | $115M |
| 2021-09-30 | $132M |
| 2021-06-30 | $115M |
| 2021-03-31 | $107M |
| 2020-09-30 | $121M |
| 2020-06-30 | $110M |
| 2020-03-31 | $90M |
| 2019-09-30 | $95M |
| 2019-06-30 | $83M |
| 2019-03-31 | $63M |
| 2018-09-30 | $58M |
| 2018-06-30 | $57M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ACAD/revenue)